Zealand Pharma A/S (ZEAL): $31.30

0.07 (+0.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Zealand Pharma A (ZEAL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Zealand Pharma A.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
9 $56.72 $35.72 $45.87 $33 39%

The Trend in the Analyst Price Target


ZEAL's average price target has moved up $1.13 over the prior 28 days.

Over the past 183 days, ZEAL's average upside potential has been 22.32%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-26 9 56.72 35.72 45.87 36.302 26.36%
2020-11-19 9 56.72 35.72 45.82 36.040 27.14%
2020-11-13 8 49.17 36.56 44.77 37.270 20.12%
2020-10-29 8 48.44 36.56 44.74 33.830 32.25%
2020-09-29 8 48.44 36.56 44.54 37.100 20.05%
2020-09-22 8 48.44 36.56 44.53 36.030 23.59%
2020-08-27 8 48.44 36.56 44.63 38.050 17.29%
2020-08-14 8 58.00 36.56 44.78 38.730 15.62%
2020-08-14 9 58.00 36.56 45.44 38.730 17.33%
2020-08-02 7 58.00 33.11 43.32 32.440 33.54%
2020-07-14 7 58.00 33.11 43.32 34.500 25.57%
2020-07-01 7 58.00 33.11 42.89 34.760 23.39%
2020-06-23 7 58.00 33.11 43.07 37.060 16.22%
2020-05-27 8 58.00 33.11 42.37 37.160 14.02%

ZEAL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The Trend in the Broker Recommendations


Over the past 92 days, ZEAL's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ZEAL as an investment opportunity.

  • The number of analysts covering the stock of ZEAL is higher than 96.38% of stocks in the small market cap category.
  • The average analyst price target of ZEAL is greater than 83.68% of stocks in the small market cap category.
  • ZEAL has a less variance in analysts' estimates than 24.38% of stocks in the small market cap category.
  • ZEAL has a higher upside potential (average analyst target price relative to current price) than 25.18% of Pharmaceutical Products stocks.

Is ZEAL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6497 seconds.